AusDiagnostics is delighted to announce the appointment of Marco Calzavara as its new Business Director for UK and Europe.
In his new role, Mr Calzavara will be responsible for operations and staff across the UK and Europe.
Mr Calzavara is the founder and former president of the esteemed biotechnology company Bioline, now owned by Meridian Bioscience. He established Bioline in 1992 in United Kingdom, growing the business from humble beginnings into a global organisation with subsidiaries throughout United Kingdom, United States, Singapore, Italy, Germany and Australia, each with an impressive network of distributors.
Announcing Mr Calzavara’s appointment, AusDiagnostics CEO Scott Gilroy said: “Marco is a respected leader and entrepreneur with more than 30 years of experience in the biotechnology sector and holds extensive knowledge in reagent formulation, production and manufacturing, regulatory affairs, legal governance, strategic enterprise, and commercialisation of R&D products to market.
“2021 continues to be one of the most rewarding years for the AusDiagnostics brand as we position from strength to strength within the global molecular diagnostics market. This union marks another significant step in AusDiagnostics’ growth journey, positioning us stronger for the future.”
Reflecting on his appointment, Mr Calzavara said: “I'm excited to be joining AusDiagnostics and leading the team in the UK. The company has great prospects with its diagnostic solutions, and I am looking forward to working with the dedicated staff and distributors to drive even greater business growth in the UK and Europe.”
Former COO of AusDiagnostics UK, Richard Hale, will transition to a Scientific Consultant position for AusDiagnostics.
About AusDiagnostics:
AusDiagnostics Pty Ltd is a leading international company that designs, manufactures, and markets a comprehensive suite of multiplexing molecular diagnostic assays and reagents. Founded in August 2006, AusDiagnostics also supports robotic instruments for in vitro diagnostics and testing in the medical, veterinary food, and water and environment industries. In the past five years, the company has expanded its reach to global customers through offices in New Zealand, the United Kingdom, and the United States. In 2018, AusDiagnostics opened a manufacturing facility in the United Kingdom to support the supply of products to its growing network of distribution partners in more than 25 countries. AusDiagnostics continues to develop new technology and conduct scientific research into innovative diagnostic methodologies for customers.
For further details, contact:
info@ausdiagnostics.com
+61 (02) 9698 8030